

Toll-Free: (800) 266-7207  For Domestic | Intl: (404) 496-4049

  • Follow
  • Follow
  • Follow

Invest Now

  • Home
  • About Us
    • Our Tribe
    • Our Mission
    • Our Values
    • Our Future
  • Medical & Wellness Testing
  • Contact Us
  • News
  • Invest Now
  • Home
  • About Us
    • Our Tribe
    • Our Mission
    • Our Values
    • Our Future
  • Contact Us
  • Medical & Wellness Testing
  • News
  • Invest Now

Study: Optical Biosensors for Virus Detection: Prospects for SARS-CoV-2/COVID-19

Nov 1, 2021 | News | 0 comments

By: Hemanth Maddali,Catherine E. Miles,Prof. Joachim Kohn,Prof. Deirdre M. O’Carroll, Chemistry Europe Published: 29 October 2020 Full Study Optical biosensors have led to significant advancements in virus detection and imaging capabilities. Coupled with...

Study: SARS-CoV-2 Transmission From People Without COVID-19 Symptoms

Nov 1, 2021 | News | 0 comments

By: Michael A. Johansson, PhD; Talia M. Quandelacy, PhD, MPH; Sarah Kada, PhD; JAMA Netw Open. 2021;4(1) Published:  January 07 2021 Full Study Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiology of coronavirus disease 2019 (COVID-19), is...

Study: Comparative evaluation of 19 reverse transcription loop-mediated isothermal amplification assays for detection of SARS-CoV-2

Nov 1, 2021 | News | 0 comments

By: Yajuan Dong, Xiuming Wu, Shenwei Li, Renfei Lu, Yingxue Li, Zhenzhou Wan, Jianru Qin, Guoying Yu, Xia Jin & Chiyu Zhang Scientific Reports volume 11, Article number: 2936 (2021) Published:  03 February 2021 Full Study Coronavirus disease 2019 (COVID-19) caused...

Study: Lateral flow tests cannot rule out SARS- CoV-2 infection

Nov 1, 2021 | News | 0 comments

By: Jonathan J Deeks, Angela E Raffle, British Medical Journal 2020;371:m4787 Published:  11 December 2020 Full Study Lateral flow devices for asymptomatic mass testing are proving controversial. At the heart of the matter is a flawed process, with the decision to...

Study: Saliva is more sensitive than nasopharyngeal or nasal swabs for diagnosis of asymptomatic and mild COVID-19 infection

Nov 1, 2021 | News | 0 comments

By: Alvin Kuo Jing Teo, Yukti Choudhury, Iain Beehuat Tan, Chae Yin Cher, Shi Hao Chew, Zi Yi Wan, Lionel Tim Ee Cheng, Lynette Lin Ean Oon, Min Han Tan, Kian Sing Chan & Li Yang Hsu Scientific...

Study: Benefits of Mobile Contact Tracing on COVID-19: Tracing Capacity Perspectives

Nov 1, 2021 | News | 0 comments

By: Uichin Lee and Auk Kim Frontiers in Public Health Published: 18 March 2021 Full Story For effectively suppressing COVID-19’s spread, contact tracing has been widely used to identify, isolate, and follow-up with those who have come in close contact with an...
« Older Entries
Next Entries »

Recent Posts

  • Beyond the Pandemic: Confronting the Triple Menace of COVID-19, Flu, and RSV with Innovative Testing Solutions
  • Unseen Casualties of the Pandemic: How COVID-19 Led to Thousands of Missed Prostate Cancer Diagnoses in England
  • Unmasking Chronic Anxiety’s 95% Misdiagnosis Rate & Need for Precision Beyond Self-Recognition
  • Essential Knowledge about Prostate Cancer for Patients
  • Empowering Health Advocates: How Clear Health Pass is Revolutionizing Preventive Care with Ethical AI

Recent Comments

No comments to show.

ABOUT US

Clear Health Pass™ LLC acts as Authorized Representative of tribal, federally chartered corporations formed under Section 17 of the Indian Reorganization Act (IRA), U.S.C. Title 25.

(800) 266-7207
(404) 496-4049

 

 

OUR TESTS

  • Clear Health Pass MDHeartPro
  • Clear Health Pass MDDiabeticPro
  • Clear Health Pass MDGeneticPro Women’s Health
  • Clear Health Pass MDAllergyPro
  • Clear Health Pass MDDrugPro
  • Clear Health Pass NIPT

OUR PARTNERS

Under Disclaimers & Regulatory Disclosures

 

    • Use of Artificial Intelligence (AI)
    • CLIA Certification and Laboratory Accreditation
    • HIPAA Compliance and Data Security
    • FDA Compliance for Laboratory-Developed Tests 
    • Tribal Sovereignty and Compliance
    • Medical Disclaimer for Lab Testing & Result Interpretation
    • Quality Assurance Commitment
    • Third-Party Vendor Compliance
    • Safe Harbor Statement
    • Privacy Policy | Terms and Conditions

 

© 2022-2025 Clear Health Pass Holdings, LLC. All rights reserved. Clear Health Pass, DrugPro, GeneticPro, DiabeticPro, and HeartPro are trademarks of Clear Health Pass Holdings, LLC. Unauthorized use of these trademarks is strictly prohibited.